Stephen Schultz | Vice President, Investor Relations |
Justin Gover | Chief Executive Officer |
Darren Cline | U.S. Chief Commercial Officer |
Chris Tovey | Chief Operating Officer |
Volker Knappertz | Chief Medical Officer |
Scott Giacobello | Chief Financial Officer |
David Lebowitz | Morgan Stanley |
Tazeen Ahmad | Bank of America |
Cory Kasimov | JPMorgan |
Phil Nadeau | Cowen and Company |
Esther Rajavelu | Oppenheimer and Company |
Yatin Suneja | Guggenheim Partners |
Douglas Tsao | H.C. Wainwright |
Danielle Brill | Piper Sandler |
David Kideckel | AltaCorp Capital |
Serge Belanger | Needham and Company |
Greetings. And welcome to the GW Pharmaceuticals Fourth Quarter and Year End 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.